The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors

We investigated the patients with solid cancers harboring Fms-like tyrosine kinase 3 (FLT3) amplification using targeted sequencing of tumor tissue specimen and FISH assay. Simultaneously, FLT3-amplified patient-derived cells (PDCs) were generated to evaluate the sensitivity to FLT3 inhibition. A pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sung Hee, Kim, Sun-Young, Kim, Kyung, Jang, Hyojin, Ahn, Soomin, Kim, Kyoung-Mee, Kim, Nayoung K.D., Park, Woongyang, Lee, Su Jin, Kim, Seung Tae, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lee, Se-Hoon, Lim, Ho Yeong, Park, Keunchil, Kang, Won Ki, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356878/
https://www.ncbi.nlm.nih.gov/pubmed/27906677
http://dx.doi.org/10.18632/oncotarget.13700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356878/
https://www.ncbi.nlm.nih.gov/pubmed/27906677
http://dx.doi.org/10.18632/oncotarget.13700

Ejemplares similares